CSPC Innovation Pharmaceutical News

New Novus: Announcement on the holding subsidiary SYS6005 antibody drug conjugate obtaining approval notice for drug clinical trials

Dec 20 15:54

New Novus: Announcement on the holding subsidiary SYS6043 antibody drug conjugate obtaining approval notice for drug clinical trials

Dec 20 15:54

New Norway: Rules of Work for Independent Directors

Dec 20 00:00

New Novus: Announcement on the estimated amount of the company\'s daily sex-related transactions in 2025

Dec 20 00:00

New Novus: Announcement on amendments to the “Articles of Association”

Dec 20 00:00

New Novus: Announcement of Resolutions of the 16th Meeting of the 6th Board of Supervisors

Dec 20 00:00

New Novus: Progress Announcement on the Use of Some Idle Raised Funds for Cash Management

Dec 20 00:00

New Novus: Notice on Convening the First Extraordinary General Meeting of Shareholders in 2025

Dec 20 00:00

New Novus: Announcement of Resolutions of the 21st Meeting of the 6th Board of Directors

Dec 20 00:00

New Novus: Articles of Association (December 2024)

Dec 20 00:00

New Novus: Board of Directors Rules of Procedure

Dec 20 00:00

New Novus: Announcement on the application documents for issuing shares to purchase assets and raise supporting funds were accepted by the Shenzhen Stock Exchange

Dec 9 00:00

New Novus: Announcement on the completion of the registration of the change in registered capital and the issuance of a business license

Dec 5 16:46

New Novus: Announcement on the holding subsidiary obtaining US FDA fast-track qualification for externally authorized drugs

Dec 4 16:00

New Novus: Announcement on the signing of a tripartite supervisory agreement on capital raising

Dec 3 15:56

New Novus: Announcement on acceptance of the holding subsidiary\'s application for the marketing of usinumab injections

Nov 26 16:22

New Novus: Announcement on the holding subsidiary obtaining a notice of approval for drug clinical trials

Nov 12 16:22

New Novus: Announcement on the controlling shareholder\'s plan to increase the company\'s share holdings

Nov 8 00:00

New Novus: Legal Opinion of Beijing Junzejun Law Firm on Witnessing the 2024 Third Extraordinary General Meeting of Shareholders of Shiyao Innovative Pharmaceutical Co., Ltd.

Oct 31 18:52

New Novus: Announcement of Resolutions of the 2024 Third Extraordinary General Meeting of Shareholders

Oct 31 18:52